Target
D(1A) dopamine receptor
Ligand
BDBM371990
Substrate
n/a
Meas. Tech.
In Vitro Binding Assay for DDR1
IC50
311±n/a nM
Citation
 Buettelmann, BKocer, BKuhn, BPrunotto, MRichter, HRitter, MRudolph, MSatz, AL Triaza-spirodecanones as DDR1 inhibitors US Patent  US10239876 Publication Date 3/26/2019 
Target
Name:
D(1A) dopamine receptor
Synonyms:
DA D1 receptor | DOPAMINE D1 | DRD1 | DRD1_HUMAN | Dopamine D1 receptor | Dopamine D1 receptor (D1R) | Dopamine D1A
Type:
Enzyme
Mol. Mass.:
49303.43
Organism:
Homo sapiens (Human)
Description:
P21728
Residue:
446
Sequence:
MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIPVAIMIVTYTRIYRIAQKQIRRIAALERAAVHAKNCQTTTGNGKPVECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCGSGETQPFCIDSNTFDVFVWFGWANSSLNPIIYAFNADFRKAFSTLLGCYRLCPATNNAIETVSINNNGAAMFSSHHEPRGSISKECNLVYLIPHAVGSSEDLKKEEAAGIARPLEKLSPALSVILDYDTDVSLEKIQPITQNGQHPT
  
Inhibitor
Name:
BDBM371990
Synonyms:
(RS)-8-(1H-Indazole-5-carbonyl)-3-[2-oxo-2-[3-(1,2,4-triazol-1-yl)pyrrolidin-1-yl]ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | US10239876, Example 54 | US10435407, Example 54
Type:
Small organic molecule
Emp. Form.:
C29H31N9O3
Mol. Mass.:
553.6149
SMILES:
O=C(CN1CN(c2ccccc2)C2(CCN(CC2)C(=O)c2ccc3[nH]ncc3c2)C1=O)N1CCC(C1)n1cncn1
Structure:
Search PDB for entries with ligand similarity: